Product Reports Resources Pricing Login Book a demo

Nanalysis

Health Tech & Medtech · Homer Glen, United States · Founded 2009 · IPO 2017

Develops portable nuclear magnetic resonance spectrometers for biotech and pharmaceutical applications MoreLess

Nanalysis Scientific Corporation is a publicly traded company specializing in the development and manufacturing of compact Magnetic Resonance Imaging (MRI) and Nuclear Magnetic Resonance (NMR) spectroscopy products. Operating in the global scientific instrumentation market, Nanalysis serves a diverse range of clients including academic institutions, pharmaceutical companies, and industrial laboratories. The company's core product line includes benchtop NMR spectrometers, high field NMR consoles, and MRI consoles, which are known for their ease of use, low maintenance, and affordability. Nanalysis generates revenue through the sale of these instruments, as well as through software packages and service contracts. Their business model focuses on providing high-resolution, portable solutions that save time and space for their clients, making advanced magnetic resonance technology accessible to smaller labs and institutions. The company is listed on the TSXV under the ticker NSCI, FRA under 1N1, and USA OTC under NSCIF.

Keywords: benchtop NMR, MRI consoles, spectroscopy, academic labs, pharmaceutical, industrial labs, high resolution, portable, low maintenance, affordable.

Valuation $23M
Revenue $31M
EBITDA $4.5M
Total funding $10–50M

Talent graph

Nanalysis's talent

Book a demo to see the people
Employees mapped 63 incl. 1 AI specialist
Founders Hidden — book a demo/100 quality score
Key operators 31 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

3 investors on Nanalysis's cap table

Sourced from Dealroom's funding and investor records.

Seed 1 investor entered at this stage
National Research Council Canada
Series B+ 2 investors entered at this stage
Prairies Economic Development Canada
Jonathan W. Ladd

Global footprint

Where Nanalysis has talent and traffic

Workforce by country
3 countries with
team presence
🇨🇦 Canada83.3%
🇩🇪 Germany7.1%
🇺🇸 United States7.1%
3 countries shown
Web traffic by country
18K monthly visits
across markets
🇺🇸 United States32.8%
🇩🇪 Germany14.4%
🇨🇦 Canada12.2%
🇮🇳 India11.7%
🇬🇧 United Kingdom11.1%
Top 5 markets shown

Market sentiment

What the market is saying about Nanalysis

An AI-synthesized read of the highest-engagement posts about Nanalysis on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Nanalysis on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.